CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Cash flows from operating activities:
Net income	$ 54,228	$ 69,463
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	20,209	15,200
Amortization	15,364	2,379
Amortization of deferred financing costs	1,196	0
Deferred income taxes	3,690	1,220
Share based compensation expense	4,222	4,668
Restructuring and other costs - non-cash	1,165	0
Stock option income tax benefit	(3,879)	(4,371)
Net interest expense on derivatives with an other-than-insignificant financing element	800	723
Equity in earnings from unconsolidated affiliates	4,248	824
Other non-cash expense	1,079	1,082
Changes in operating assets and liabilities, net of acquisitions:
Accounts and notes receivable-trade, net	(25,597)	(28,706)
Inventories, net	(34,006)	(14,727)
Prepaid expenses and other current assets	(24,072)	(5,745)
Other noncurrent assets, net	15,954	1,123
Accounts payable	11,528	5,569
Accrued liabilities	(21,186)	(15,861)
Income taxes payable	10,545	11,516
Other noncurrent liabilities	(15,535)	371
Net cash provided by operating activities	19,953	44,728
Cash flows from investing activities:
Capital expenditures	(18,642)	(11,774)
Cash paid for acquisitions of businesses, net of cash acquired	0	(5,582)
Expenditures for identifiable intangible assets	(146)	(254)
Purchase of Company-owned life insurance policies	(1,577)	0
Proceeds from sale of property, plant and equipment, net	166	52
Net cash used in investing activities	(20,199)	(17,558)
Cash flows from financing activities:
Net change in short-term borrowings	11,155	3,403
Cash paid for treasury stock	(30,869)	(73,679)
Cash dividends paid	(7,847)	(7,131)
Cash paid for contingent consideration on prior acquisitions	(1,781)	0
Cash paid for acquisition of noncontrolling interests of consolidated subsidiaries	0	(15,545)
Proceeds from long-term borrowings	4,571	51,100
Repayments on long-term borrowings	(5,171)	(1,951)
Proceeds from exercise of stock options	14,483	22,171
Excess tax benefits from share based compensation	3,879	4,371
Net interest payments on derivatives with an other-than-insignificant financing element	(800)	(723)
Net cash used in financing activities	(12,380)	(17,984)
Effect of exchange rate changes on cash and cash equivalents	2,844	26,040
Net decrease in cash and cash equivalents	(9,782)	35,226
Cash and cash equivalents at beginning of period	77,128	540,038
Cash and cash equivalents at end of period	$ 67,346	$ 575,264